Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             33 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Albumin-like material in urine Comper, Wayne D.

66 S92 p. S65-S66
artikel
2 Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study Ibsen, Hans

66 S92 p. S56-S58
artikel
3 Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Mann, Johannes F.E.

66 S92 p. S59-S62
artikel
4 Albuminuria as a surrogate marker for drug development: A European Regulatory perspective Calvo, Gonzalo

66 S92 p. S126-S127
artikel
5 Albuminuria: Marker or target in indigenous populations Hoy, Wendy

66 S92 p. S25-S31
artikel
6 Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? De Zeeuw, Dick

66 S92 p. S2-S6
artikel
7 Albuminuria predicting outcome in diabetes: Incidence of microalbuminuria in Asia–Pacific Rim Weir, Matthew R.

66 S92 p. S38-S39
artikel
8 An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population Verhave, Jacobien C.

66 S92 p. S18-S21
artikel
9 Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathy Jacobsen, Peter

66 S92 p. S108-S110
artikel
10 Cardiovascular risk in chronic kidney disease Anavekar, Nagesh S.

66 S92 p. S11-S15
artikel
11 Demographic and epidemiologic transition in the developing world: Role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease Correa-Rotter, Ricardo

66 S92 p. S32-S37
artikel
12 Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease Mitch, William E.

66 S92 p. S97-S98
artikel
13 Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Segura, Julian

66 S92 p. S45-S49
artikel
14 Framingham score and microalbuminuria: Combined future targets for primary prevention? Asselbergs, Folkert W.

66 S92 p. S111-S114
artikel
15 Glomerular filtration of albumin: How small is the sieving coefficient? Deen, William M.

66 S92 p. S63-S64
artikel
16 Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria Palmer, Andrew J.

66 S92 p. S118-S120
artikel
17 Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial Hunsicker, Lawrence G.

66 S92 p. S99-S101
artikel
18 Inclusion of albumin as a target in therapy guidelines: Guidelines for chronic kidney disease Warnock, David G.

66 S92 p. S121-S123
artikel
19 Inclusion of albuminuria in hypertension and heart guidelines Bakris, George

66 S92 p. S124-S125
artikel
20 Introduction De Zeeuw, Dick

66 S92 p. S1
artikel
21 Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy Alexander, Charles M.

66 S92 p. S115-S117
artikel
22 Mechanism of albuminuria associated with cardiovascular disease and kidney disease Russo, Leileata M.

66 S92 p. S67-S68
artikel
23 Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2 Mogensen, Carl Erik

66 S92 p. S40-S41
artikel
24 Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn Study Stehouwer, Coen D.A.

66 S92 p. S42-S44
artikel
25 Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria Anavekar, Nagesh S.

66 S92 p. S50-S55
artikel
26 Prevalence of albuminuria in Australia: The AusDiab Kidney Study Atkins, Robert C.

66 S92 p. S22-S24
artikel
27 Proteinuria and hypertensive nephrosclerosis in African Americans Toto, Robert D.

66 S92 p. S102-S104
artikel
28 Proteinuria predicting outcome in renal disease: Nondiabetic nephropathies (REIN) Remuzzi, Giuseppe

66 S92 p. S90-S96
artikel
29 The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes Forbes, Josephine M.

66 S92 p. S105-S107
artikel
30 Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future? Gansevoort, Ron T.

66 S92 p. S7-S10
artikel
31 Which albumin should we measure? Becker, Gavin J.

66 S92 p. S16-S17
artikel
32 Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC Brinkman, Jacoline W.

66 S92 p. S69-S75
artikel
33 Why is proteinuria an ominous biomarker of progressive kidney disease? Zandi-Nejad, Kambiz

66 S92 p. S76-S89
artikel
                             33 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring